Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Metallothioneins (MTs) are crucial for metal homeostasis, particularly zinc and copper.
• Copper dysregulation in the brain is linked to aging, neurodegeneration, and Parkinson's disease (PD).
• Alpha-synuclein aggregation is a key factor in PD and other alpha-synucleinopathies.

Purpose of the Study:

• To review the role of MTs in copper dyshomeostasis.
• To examine the involvement of MTs in alpha-synuclein aggregation.
• To explore MTs as potential biomarkers and therapeutic targets for PD.

Main Methods:

• Literature review of studies on MTs, copper metabolism, and alpha-synuclein.
• Analysis of existing data on MT expression in neurological disorders.
• In vitro studies examining MT-alpha-synuclein interactions.

Main Results:

• MTs influence copper bioavailability, affecting neuronal function and oxidative stress.
• Copper binding to alpha-synuclein promotes aggregation, a hallmark of PD.
• MT-3 isoform interacts with copper-bound alpha-synuclein and is found in pathological aggregates.

Conclusions:

• MTs play a significant role in copper dyshomeostasis and alpha-synuclein aggregation in PD.
• Dysregulation of MT isoforms (MT-1/2, MT-3) is observed in alpha-synucleinopathies.
• MTs represent promising biomarkers and therapeutic targets for neurodegenerative diseases.